Rikke Bæk Holmgaard

Title: Rikke Bæk Holmgaard: Innovator in Antibody Development

Introduction

Rikke Bæk Holmgaard is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly in the development of anti-PD-1 antibodies. With a total of 2 patents, his work has the potential to impact cancer treatment and therapeutic approaches.

Latest Patents

Holmgaard's latest patents include innovative methods and compositions related to anti-PD-1 antibodies. These antibodies specifically bind to human PD-1 and antagonize its function. The patents also encompass pharmaceutical compositions that include these antibodies, nucleic acids encoding them, expression vectors, and host cells for their production. Furthermore, the patents detail methods for treating subjects using these antibodies, showcasing their therapeutic potential.

Career Highlights

Throughout his career, Rikke Bæk Holmgaard has worked with notable organizations such as Agenus Inc. and Memorial Sloan Kettering Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Holmgaard has collaborated with esteemed colleagues, including Marc A Van Dijk and Nicholas Stuart Wilson. These partnerships have facilitated the advancement of his research and the development of innovative therapeutic solutions.

Conclusion

Rikke Bæk Holmgaard is a distinguished inventor whose work in anti-PD-1 antibodies is paving the way for new cancer treatments. His contributions to the field of immunology are noteworthy and continue to inspire future innovations.